Acute Disseminated Encephalomyelitis (ADEM): Diagnostic Criteria, Pathophysiology, and Clinical Features
Diagnostic Criteria
ADEM diagnosis requires acute or subacute onset of multifocal neurological deficits with encephalopathy, supported by MRI findings of large, confluent T2 brain lesions, and exclusion of alternative diagnoses 1, 2. The diagnosis is fundamentally clinical and radiological, with no single confirmatory test available 3, 4.
Core Diagnostic Requirements:
- Altered mental status (mandatory): Confusion, disorientation, behavioral changes, or other cognitive impairments 2
- Multifocal neurological deficits: Motor deficits (80% of cases), sensory deficits, brainstem signs, ataxia 5
- Encephalopathy: Distinguished from encephalitis by the presence of brain inflammation 2
- MRI findings: Large, confluent T2 hyperintense lesions, typically bilateral and asymmetric, involving white matter 1
Supporting Features:
- Preceding trigger (4 days to ~4 weeks prior): Viral infection (most common) or vaccination 1, 6
- CSF findings: Highly variable; normal in 20% of cases. May show pleocytosis (neutrophilic or lymphocytic), elevated protein. Notably, oligoclonal bands are absent in typical ADEM (presence suggests MS) 1, 5
- Monophasic course: Single clinical episode distinguishes ADEM from MS 5
Critical Diagnostic Pitfall:
Up to 35% of patients initially diagnosed with ADEM will ultimately develop MS upon long-term follow-up 5. No reliable criteria exist to differentiate a first MS attack from monophasic ADEM at presentation. Therefore, ADEM should be considered a clinical syndrome descriptor rather than a definitive diagnosis until prolonged follow-up (months to years) confirms monophasic disease 5.
Pathophysiology
ADEM represents an immune-mediated demyelinating disorder triggered by post-infectious or post-vaccination immune dysregulation in genetically susceptible individuals 6, 7, 8.
Key Pathophysiologic Mechanisms:
- Molecular mimicry: Cross-reactivity between infectious antigens and myelin proteins (myelin basic protein, myelin oligodendrocyte glycoprotein) 6, 8
- Blood-brain barrier disruption: Allows inflammatory cell infiltration into CNS 6
- Loss of immune tolerance: Breakdown of regulatory T-cell function 6
- Perivascular demyelination: Pathologic hallmark showing zones of myelin loss with relative axonal sparing 9
- Complement and antibody deposition: Intralesional complement and IgG deposits on histopathology 1
The inflammatory cascade results in widespread demyelination affecting both brain and spinal cord, with predilection for white matter structures 6, 7.
Clinical Features
Typical Presentation:
- Acute to subacute onset (hours to days) of neurological symptoms 3, 6
- Motor deficits (80%): Weakness, hemiparesis, quadriparesis 5
- Encephalopathy: Altered consciousness, confusion, behavioral changes 2, 5
- Brainstem signs: Cranial nerve palsies, ataxia, dysarthria 5
- Sensory deficits: Numbness, paresthesias 5
- Seizures: Occur in subset of patients 1
- Sphincter dysfunction: Urinary retention or incontinence 1
MOG-IgG Associated ADEM:
Consider MOG-IgG testing in patients with 1:
- Diagnosis of "ADEM," "recurrent ADEM," "multiphasic ADEM," or "ADEM-ON"
- Acute respiratory insufficiency, disturbance of consciousness, behavioral changes, or seizures with demyelination on MRI
- Disease onset 4 days to ~4 weeks post-vaccination
- Absence of CSF oligoclonal bands
Atypical Presentation in Older Adults
ADEM in middle-aged and elderly patients is rare but presents with distinctive features that frequently lead to misdiagnosis 10, 9.
Key Differences in Elderly Presentation:
Psychiatric manifestations predominate: Behavioral changes, mutism, psychosis, acute confusion are more prominent than motor deficits 10. This often results in initial psychiatric ward admission rather than neurological evaluation 10.
Diagnostic challenges specific to older adults 9:
- Imaging mimics other diagnoses: Lesions may resemble metastases, primary CNS tumors, or stroke 9
- Contrast enhancement: Present in some elderly ADEM cases, further suggesting neoplasm 9
- Restricted diffusion: May occur on DWI, mimicking acute stroke 9
- Preceding infection less obvious: Only documented in subset of elderly cases 10
Pathological confirmation often required: Due to atypical imaging and clinical features raising concern for malignancy, biopsy or autopsy may be necessary for definitive diagnosis in elderly patients 9. Histopathology shows characteristic perivascular myelin loss with axonal sparing 9.
Why ADEM is Rare in Elderly:
Two proposed mechanisms 10:
- Age-related differences in immune response to infectious agents
- Historical underdiagnosis prior to widespread MRI availability
Clinical Approach to Suspected ADEM in Elderly:
- Maintain broad differential: Include stroke, tumor, vasculitis, infectious encephalitis 9
- Consider travel history: Cases reported following travel to endemic regions 10
- Lower threshold for biopsy: When imaging suggests alternative diagnosis but clinical course atypical 9
- Trial of corticosteroids: Fair-to-good recovery reported with steroid treatment even in elderly 10
Prognosis:
Most patients improve with high-dose methylprednisolone 5, 7. In adults, outcomes range from complete recovery (46%) to minor deficits (35%) to moderate deficits (12%), with mortality in ~8% 5. Elderly patients show fair-to-good recovery with steroid treatment 10, though data are limited.
Critical monitoring requirement: All ADEM patients require long-term follow-up (minimum 6-12 months) with repeat MRI to distinguish monophasic ADEM from first presentation of MS 4, 5.